Biopharmaceutical industry and healthcare are being transformed by a variety of novel technolgies coming into research and business practises. From artificial intelligence and big data tools, to quantum computing, next generation proteomics, and virtual reality -- novel technologies are disrupting the traditional research and business models, and helping innovate at a greater scale, faster, and cheaper.
The race for adopting new machine learning (ML), deep learning (DL) and related technologies (for simplicity -- “artificial intelligence”/”AI”) keeps …
The newly organized research project “MELLODDY” (Machine Learning Ledger Orchestration for Drug Discovery), involving ten large pharma companies and seven …
A historically significant milestone has just been reached by Oxford, UK-based Exscientia, which used its artificial intelligence (AI)-based drug discovery …
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.